TOKYO, Feb. 4, 2025 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the following changes to its management structure effective April 1, 2025. Regarding the Changes in Management Structure Astellas aims to create and…
